Author Archive

B2B 2.0

Peter von DyckWhile the FDA’s November 2009 hearings on social media regulatory concerns focused primarily on guidelines governing pharma’s consumer communications, one issue was largely overlooked during the hearings and ignored in the media coverage: the use of highly targeted social media sites for healthcare companies to communicate with other businesses within the industry, as well as service providers across the industry. And though FDA’s oversight might indicate otherwise, this brand of business-to-business communication via secure online market places — used to accelerate dealmaking, sales and collaboration — is expanding. Read more »